Autoantibodies to NR2A Peptide of the Glutamate/NMDA Receptor in Patients with Seizure Disorders in Neuropsychiatric Systemic Lupus Erythematosus
Anti-NR2A concentrations in serum from SLE patients and controls. (a) Serum anti-NR2A levels in SLE patients and controls using ELISA. Horizontal lines represent the median. (b) Comparison of serum anti-NR2A between NPSLE and non-NPSLE patients with ELISA. (c) Serum anti-NR2A measured by ELISA in NPSLE patients with seizure and those without seizure.